• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性淋巴结的癌症组织学可预测淋巴结阳性 IV 期结直肠癌患者的预后。

Cancer histology in metastatic lymph node predicts prognosis in patients with node-positive stage IV colorectal cancer.

机构信息

Department of Surgery, National Hospital Organization Minami Wakayama Medical Center, Tanabe, Wakayama, Japan.

出版信息

PeerJ. 2024 Jul 9;12:e17702. doi: 10.7717/peerj.17702. eCollection 2024.

DOI:10.7717/peerj.17702
PMID:39006028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11243965/
Abstract

BACKGROUND

Appropriate prognostic indicators are required for patients with stage IV colorectal cancer (CRC). Lymph node metastasis mainly involves four histological types of CRC. Some metastatic lymph nodes (mLNs) showing cribriform carcinoma are associated with distant metastasis in patients with node-positive CRC and are correlated with recurrence and survival in stage III disease. However, the significance of mLN histology in the prognosis of patients with node-positive stage IV disease remains unclear.

METHODS

We enrolled 449 consecutive patients with CRC who underwent primary tumor resection with lymph node dissection between January 2011 and November 2018. This study included 88 patients with node-positive stage IV CRC and synchronous or metachronous distant metastases. We retrospectively investigated the association between cancer histology in the mLNs based on our classification and cancer-specific survival (CSS) in patients with node-positive stage IV CRC.

RESULTS

Kaplan-Meier analysis showed that CSS was better in patients with CRC and all the mLNs showing tubular-type carcinoma. In contrast, patients with at least some mLNs showing poorly differentiated-type carcinoma had poor prognosis. Multivariate analysis showed that "all mLNs showing tubular-type carcinoma" was an independent good prognostic factor for CSS in patients with node-positive stage IV CRC. In addition, "at least some mLNs showing poorly differentiated-type carcinoma" was an independent poor prognostic factor for CSS in patients with node-positive stage IV disease.

CONCLUSIONS

The histological type of the mLN may indicate a better or poor prognosis for patients with stage IV CRC.

摘要

背景

对于 IV 期结直肠癌(CRC)患者,需要适当的预后指标。淋巴结转移主要涉及 CRC 的四种组织学类型。一些表现为筛状癌的转移性淋巴结(mLN)与阳性淋巴结 CRC 患者的远处转移有关,与 III 期疾病的复发和生存相关。然而,mLN 组织学在阳性淋巴结 IV 期疾病患者预后中的意义仍不清楚。

方法

我们纳入了 2011 年 1 月至 2018 年 11 月期间接受原发肿瘤切除术和淋巴结清扫术的 449 例连续 CRC 患者。本研究包括 88 例阳性淋巴结 IV 期 CRC 伴同步或异时性远处转移的患者。我们回顾性地研究了基于我们分类的 mLN 中的癌症组织学与阳性淋巴结 IV 期 CRC 患者的癌症特异性生存(CSS)之间的关联。

结果

Kaplan-Meier 分析显示,CRC 患者和所有 mLN 均显示管状型癌的 CSS 更好。相比之下,至少有一些 mLN 显示低分化型癌的患者预后较差。多变量分析显示,“所有 mLN 均显示管状型癌”是阳性淋巴结 IV 期 CRC 患者 CSS 的独立良好预后因素。此外,“至少有一些 mLN 显示低分化型癌”是阳性淋巴结 IV 期疾病患者 CSS 的独立不良预后因素。

结论

mLN 的组织学类型可能提示 IV 期 CRC 患者的预后较好或较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ff/11243965/657d9f608297/peerj-12-17702-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ff/11243965/33c73dbf510b/peerj-12-17702-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ff/11243965/657d9f608297/peerj-12-17702-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ff/11243965/33c73dbf510b/peerj-12-17702-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ff/11243965/657d9f608297/peerj-12-17702-g002.jpg

相似文献

1
Cancer histology in metastatic lymph node predicts prognosis in patients with node-positive stage IV colorectal cancer.转移性淋巴结的癌症组织学可预测淋巴结阳性 IV 期结直肠癌患者的预后。
PeerJ. 2024 Jul 9;12:e17702. doi: 10.7717/peerj.17702. eCollection 2024.
2
Histology of metastatic colorectal cancer in a lymph node.转移性结直肠癌淋巴结的组织学检查。
PLoS One. 2023 Apr 13;18(4):e0284536. doi: 10.1371/journal.pone.0284536. eCollection 2023.
3
The number of metastatic lymph nodes exhibiting poorly differentiated clusters predicts survival in patients with pStage III colorectal cancer.表现为低分化簇状的转移性淋巴结数量可预测pIII期结直肠癌患者的生存情况。
Int J Colorectal Dis. 2016 Feb;31(2):283-90. doi: 10.1007/s00384-015-2393-5. Epub 2015 Sep 28.
4
Prognostic significance of negative lymph node count in microsatellite instability-high colorectal cancer.微卫星不稳定高结直肠癌中阴性淋巴结计数的预后意义。
World J Surg Oncol. 2024 Jul 19;22(1):186. doi: 10.1186/s12957-024-03469-4.
5
Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined.淋巴结比率作为Ⅲ期结直肠癌的独立预后指标:尤其适用于检查的淋巴结少于12个的情况。
Tumour Biol. 2014 Nov;35(11):11685-90. doi: 10.1007/s13277-014-2484-x. Epub 2014 Aug 21.
6
A reappraisal of lymph node dissection in colorectal cancer during primary surgical resection.结直肠癌原发灶切除术中淋巴结清扫的再评价。
World J Surg Oncol. 2020 May 17;18(1):97. doi: 10.1186/s12957-020-01863-2.
7
Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.在III期结直肠癌中,阴性淋巴结与阳性淋巴结比例比传统的淋巴结状态是更好的预测指标。
Oncotarget. 2016 Nov 1;7(44):72290-72299. doi: 10.18632/oncotarget.10806.
8
Lymph node ratio prognosticates overall survival in patients with stage IV colorectal cancer.淋巴结比率可预测 IV 期结直肠癌患者的总生存。
Tech Coloproctol. 2024 Aug 23;28(1):115. doi: 10.1007/s10151-024-02984-6.
9
Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.中国多中心 T1 期结直肠癌患者淋巴结转移的预后价值。
World J Gastroenterol. 2017 Dec 28;23(48):8582-8590. doi: 10.3748/wjg.v23.i48.8582.
10
Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.大转移淋巴结大小,尤其是超过2厘米:淋巴结阳性胃癌预后不良的独立预测因素。
World J Surg. 2008 Feb;32(2):262-6. doi: 10.1007/s00268-007-9158-4.

本文引用的文献

1
Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma.IV期结肠腺癌患者对曲氟尿苷/替匹嘧啶(TAS-102)三线治疗的完全缓解。
Explor Target Antitumor Ther. 2023;4(2):307-315. doi: 10.37349/etat.2023.00136. Epub 2023 Apr 27.
2
Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival.诊断时同步转移性结直肠癌循环肿瘤 DNA 分析预测总体患者生存。
Int J Mol Sci. 2023 May 8;24(9):8438. doi: 10.3390/ijms24098438.
3
Genomic landscape and survival analysis of ctDNA "neo- wild-type" patients with originally mutant metastatic colorectal cancer.
原发性突变转移性结直肠癌ctDNA“新野生型”患者的基因组图谱与生存分析
Front Oncol. 2023 Mar 29;13:1160673. doi: 10.3389/fonc.2023.1160673. eCollection 2023.
4
Histology of metastatic colorectal cancer in a lymph node.转移性结直肠癌淋巴结的组织学检查。
PLoS One. 2023 Apr 13;18(4):e0284536. doi: 10.1371/journal.pone.0284536. eCollection 2023.
5
Impact of perineural invasion on the outcome of patients with synchronous colorectal liver metastases treated with neoadjuvant chemotherapy and surgery.新辅助化疗和手术治疗同步结直肠肝转移患者中神经周围侵犯对预后的影响。
Clin Transl Oncol. 2023 Aug;25(8):2523-2531. doi: 10.1007/s12094-023-03138-0. Epub 2023 Apr 7.
6
Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients With Stage IV Colorectal Cancer After Surgery.患者来源的肿瘤类器官可预测 IV 期结直肠癌患者手术后的无进展生存期。
Dis Colon Rectum. 2023 May 1;66(5):733-743. doi: 10.1097/DCR.0000000000002511. Epub 2023 Mar 9.
7
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression.转移性结直肠癌的新视野:CD44表达的预后作用
Cancers (Basel). 2023 Feb 14;15(4):1212. doi: 10.3390/cancers15041212.
8
Construction of a DDR-related signature for predicting of prognosis in metastatic colorectal carcinoma.构建用于预测转移性结直肠癌预后的DDR相关特征。
Front Oncol. 2023 Feb 1;13:1043160. doi: 10.3389/fonc.2023.1043160. eCollection 2023.
9
The Significance of the D-Dimer Level as a Prognostic Marker for Survival and Treatment Outcomes in Patients With Stage IV Colorectal Cancer.D-二聚体水平作为 IV 期结直肠癌患者生存和治疗结局的预后标志物的意义。
In Vivo. 2023 Jan-Feb;37(1):440-444. doi: 10.21873/invivo.13097.
10
The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer.四期结直肠癌治疗后 CEA 结果与影像学改变的预后临床经验。
Sci Rep. 2022 Nov 22;12(1):20075. doi: 10.1038/s41598-022-24187-5.